2022
Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis
Deng L, Li P, Zhang X, Jiang Q, Turner D, Zhou C, Gao Y, Qian F, Zhang C, Lu H, Zou H, Vermund S, Qian H. Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis. Scientific Reports 2022, 12: 20763. PMID: 36456577, PMCID: PMC9714387, DOI: 10.1038/s41598-022-24220-7.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 reinfectionSystematic reviewReinfection incidenceHazard ratioCase reportIncidence ratePrior SARS-CoV-2 infectionSARS-CoV-2 infectionIncidence of reinfectionInfection-naïve individualsRisk of reinfectionSARS-CoV-2 variantsRandom-effects modelSARS-CoV-2Web of ScienceCohort studyReinfection riskReinfection casesPrior infectionLower riskNew infectionsOmicron variantReinfectionInfection incidenceIncidence
1992
Population-Based Monitoring of an Urban HIV/AIDS Epidemic: Magnitude and Trends in the District of Columbia
Rosenberg P, Levy M, Brundage J, Petersen L, Karon J, Fears T, Gardner L, Gail M, Goedert J, Blattner W, Ryan C, Vermund S, Biggar R. Population-Based Monitoring of an Urban HIV/AIDS Epidemic: Magnitude and Trends in the District of Columbia. JAMA 1992, 268: 495-503. DOI: 10.1001/jama.1992.03490040071028.Peer-Reviewed Original ResearchHuman immunodeficiency virusHIV infectionAIDS incidenceHIV prevalenceDistrict of ColumbiaDrug usersWhite menBlack menPopulation-based monitoringHIV infection incidenceImmunodeficiency syndrome (AIDS) epidemicHIV prevalence ratesHIV/AIDS epidemicHIV seroprevalenceMale patientsHIV incidenceSentinel hospitalsHIV transmissionImmunodeficiency virusHospital patientsSentinel populationPrevalence ratesColumbia residentsInfection incidenceCivilian applicants